The AFL announced that it did not authorize an arrangement between Geelong and one of their players that would have permitted continued participation while limiting the club’s legal exposure. The player in question had experienced multiple concussions. Following widespread objections from the AFL Players’ Association, former players, and coaches, Geelong terminated the agreement on Thursday.
According to an AFL statement, a Geelong player was declared fit to play following an assessment by an AFL Concussion Panel and subsequently signed a letter acknowledging potential risks while attempting to waive certain future legal rights. The document was never submitted to or approved by either the AFL or the AFLPA. Geelong subsequently informed the league that it would remove the waiver provision while noting that the player continues to recognize potential hazards.
James Gallagher, chief executive of the AFLPA, contended that the arrangement could violate both league rules and Australian legislation. He stated that organizations have an obligation to maintain safe working conditions and cannot unilaterally eliminate contractual obligations or sidestep health and safety responsibilities. Gallagher emphasized that no player may resume participation without medical clearance.
Geelong acknowledged that the letter extended beyond its intended scope and recognizes that the AFLPA was not involved in the process. The club stated it was not attempting to alter the standard AFL playing contract or evade health and safety obligations. The club noted extensive prior discussions with the player, their family, and representatives regarding the player’s concussion background, supported by medical guidance from the club’s Chief Medical Officer and the AFL Concussion Panel.
The matter reflects ongoing concerns about brain injuries in professional Australian football. A legal action involving more than 100 former AFL players, led by former Geelong player Max Rooke, has been proceeding in Victorian courts and is anticipated to advance to trial next year.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI